OPMXF yields 2.74% · MRK yields 2.76%● Live data
📍 OPMXF pulled ahead of the other in Year 1
Combined, OPMXF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OPMXF + MRK for your $10,000?
Operadora de Sites Mexicanos, S.A. de C.V. engages in building, installing, maintaining, operating, leasing, and marketing of various types of towers and other support structures for the telecommunications sector in Mexico. It also provides various base transceiver station site construction services comprises selection and acquisition of the property, and installation and operation of equipment, as well as physical spaces and other non-electronic elements for the installation of service networks. The company provides base transceiver station site construction services for guyed towers, self-supporting towers, monopole towers, and masts. Operadora de Sites Mexicanos, S.A. de C.V. was incorporated in 2015 and is based in Mexico City, Mexico. Operadora de Sites Mexicanos, S.A. de C.V. was formerly a subsidiary of Telesites, S.A.B. de C.V.
Full OPMXF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.